Lentils for Cancer Risk Reduction

Research suggests that lentils and related pulse foods may offer several biological properties relevant to cancer risk reduction, including effects on gut microbiome composition, metabolic health markers, and the presence of bioactive compounds such as GABA, though the direct evidence linking lentils specifically to reduced cancer risk is limited in this particular set of studies. The available evidence includes a mouse study showing that pulse consumption significantly altered gut bacterial balance in ways generally associated with better metabolic health, a review highlighting GABA content in pulses and its various physiological associations, and a randomized controlled trial in women with PCOS demonstrating improvements in cardio-metabolic markers following a pulse-based diet — none of which measured cancer outcomes directly. Studies indicate that the broader context of this research touches on mechanisms, such as gut microbiome shifts and reduced metabolic dysfunction, that are discussed in the wider scientific literature as potentially relevant to cancer biology, but this collection does not provide direct clinical evidence that lentil consumption reduces cancer risk in humans. Readers should note that the studies here vary considerably in design, population, and scope, and that one included study concerns global mortality trends with no direct bearing on lentils or cancer, which underscores the importance of interpreting this evidence cautiously and within its appropriate limitations.